Insider trading

Period: 120 months Stock: AGL + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

147 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

147 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

147 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

147 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
147 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
147 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

147 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Jun 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$104.30K 5,396 at 19.33
33.2%
9 Jun 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$112.77K 5,396 at 20.90
33.2%
31 May 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$106.68K 5,396 at 19.77
33.2%
27 May 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$105.64K 5,396 at 19.58
33.2%
25 May 2022
SMITH MICHAEL L Director · indirect
Sold, plan not stated
$2.85M 145,874 at 19.53
97.2%
Sold half or more
11 May 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$86.07K 5,396 at 15.95
33.2%
10 May 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated 2×
$88.86K 5,396 at 16.47
33.2%
28 Apr 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$98.74K 5,396 at 18.30
33.2%
27 Apr 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$100.77K 5,396 at 18.68
33.2%
22 Apr 2022
Desai Veeral Chief Strategy & Dev. Officer
Sold, plan not stated
$535.78K 26,789 at 20.00
8.8%
21 Apr 2022
Desai Veeral Chief Strategy & Dev. Officer
Sold, plan not stated 2×
$1.63M 79,568 at 20.54
22.2%
20 Apr 2022
Desai Veeral Chief Strategy & Dev. Officer
Sold, plan not stated
$2.38M 106,357 at 22.34
27.7%
19 Apr 2022
Desai Veeral Chief Strategy & Dev. Officer
Sold, plan not stated
$2.42M 106,357 at 22.74
27.7%
19 Apr 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$139.39K 6,296 at 22.14
36.7%
18 Apr 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$146.64K 6,477 at 22.64
37.4%
7 Apr 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$67.68K 2,706 at 25.01
4.1%
16 Mar 2022
Desai Veeral Chief Strategy & Dev. Officer
Sold, plan not stated
$4.03M 197,291 at 20.41
43.0%
16 Mar 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$750.53K 37,155 at 20.20
35.8%
15 Mar 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$1.53M 79,457 at 19.25
54.4%
Sold half or more
15 Mar 2022
Sold, plan not stated 2×
$588.37K 30,808 at 19.10
20.9%
14 Mar 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated 3×
$1.67M 81,537 at 20.44
55.0%
Sold half or more
31 Dec 2021
Halkias Theodore Chief Business Officer
Sold, plan not stated
$32.01K 1,162 at 27.55
17.6%
30 Dec 2021
Halkias Theodore Chief Business Officer
Sold, plan not stated
$333.59K 12,113 at 27.54
69.0%
Sold half or more
29 Dec 2021
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$124.34K 4,685 at 26.54
6.6%
28 Dec 2021
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$375.55K 14,055 at 26.72
16.5%
27 Dec 2021
Halkias Theodore Chief Business Officer
Sold, plan not stated
$153.70K 5,583 at 27.53
50.7%
Sold half or more
23 Dec 2021
Halkias Theodore Chief Business Officer
Sold, plan not stated
$581.83K 21,142 at 27.52
79.6%
Sold half or more
17 Dec 2021
Danieley Joan Chief Administrative Officer
Sold, plan not stated 2×
$491.40K 21,481 at 22.88
79.8%
Sold half or more
16 Dec 2021
Danieley Joan Chief Administrative Officer
Sold, plan not stated
$81.43K 3,519 at 23.14
39.3%
15 Dec 2021
Danieley Joan Chief Administrative Officer
Sold, plan not stated 2×
$571.37K 25,000 at 22.85
82.1%
Sold half or more
17 Nov 2021
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$118.34K 4,685 at 25.26
5.2%
16 Nov 2021
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$118.86K 4,685 at 25.37
4.9%
4 Nov 2021
Sobotka Glenn Chief Accounting Officer
Sold, plan not stated
$3.78M 150,000 at 25.19
97.9%
Sold half or more
4 Nov 2021
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$467.53K 18,560 at 25.19
16.4%
3 Nov 2021
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$7.50K 300 at 25.00
0.3%
14 Sep 2021
CD&R Investment Associates IX, Ltd. 10% owner · indirect
Sold, plan not stated
$518.87M 17,904,257 at 28.98
8.0%
14 Sep 2021
Mansukani Sharad Director
Sold, plan not stated
$4.53M 156,250 at 28.98
11.3%
14 Sep 2021
Desai Veeral Chief Strategy & Dev. Officer
Sold, plan not stated
$3.51M 121,001 at 28.98
31.6%
14 Sep 2021
Sell Steven CEO & President
Sold, plan not stated
$2.90M 100,000 at 28.98
100%
Sold half or more
14 Sep 2021
Halkias Theodore Chief Business Officer · indirect
Sold, plan not stated
$2.90M 100,000 at 28.98
100%
Sold half or more
14 Sep 2021
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$2.12M 73,018 at 28.98
39.1%
14 Sep 2021
Dombro Lisa Exper. & Innovation Officer
Sold, plan not stated
$1.78M 61,543 at 28.98
83.7%
Sold half or more
14 Sep 2021
Halkias Theodore Chief Business Officer
Sold, plan not stated
$1.70M 58,553 at 28.98
91.5%
Sold half or more
14 Sep 2021
Sold, plan not stated
$444.61K 15,342 at 28.98
9.4%
14 Sep 2021
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$332.55K 11,475 at 28.98
67.9%
Sold half or more
19 Apr 2021
Richards Clay Director
Bought
$499.10K 21,700 at 23.00
312%
First buy on file
19 Apr 2021
Bought
$115.00K 5,000 at 23.00
71.9%
First buy on file
Showing 101–147 of 147. ← Newer Page 3 of 3